Apatinib for Patients With Sorafenib-Refractory Advanced Hepatitis B Virus Related Hepatocellular Carcinoma: Results of a Pilot Study

Cancer Control - United States
doi 10.1177/1073274819872216
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

A Study on the Relationship of Hepatitis B Virus With Hepatocellular Carcinoma

IOSR Journal of Pharmacy and Biological Sciences
2014English

Liver Transplantation for Hepatitis B Virus-Related Hepatocellular Carcinoma in Hong Kong

Journal of Clinical and Translational Hepatology
2018English

Liver Regeneration Accelerates Hepatitis B Virus-Related Tumorigenesis of Hepatocellular Carcinoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Sorafenib Alone Versus Sorafenib Combined With Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

Radiology
Nuclear MedicineRadiologyImaging
2013English

Efficacy and Safety of TACE in Combination With Sorafenib for the Treatment of TACE-refractory Advanced Hepatocellular Carcinoma in Chinese Patients: A Retrospective Study

OncoTargets and Therapy
OncologyPharmacology
2017English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

Prevention by Lamivudine of Hepatocellular Carcinoma in Patients Infected With Hepatitis B Virus

Gut and Liver
HepatologyGastroenterology
2007English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Prognostic Nomogram for Post-Surgical Treatment With Adjuvant TACE in Hepatitis B Virus-Related Hepatocellular Carcinoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy